is semaglutide generic for wegovy Novo Nordisk braces challenge to Ozempic, in China Skinny jabs': weight-loss drugs set

New Delhi: Drug major Cipla Limited has received clearance from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase III...

Integrates into Your Healthy LifestyleFor best results, take two capsules daily with a meal, alongside a balanced diet and regular exercise

To receive new posts and support my work, consider becoming a free or paid subscriber.This episode opens with something personal: a thank you.Because I was only able to return to D.C

Insert the needle into the skin fold at the selected injection site

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

SHANGHAI, March 6 () - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting competition in a market analysts expect to be worth billions in coming years.The injection belongs to the class of GLP-1 receptor agonist drugs sold locally by drugmakers such as Novo Nordisk, Eli Lilly, and Innovent Biologics.